{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiatsdsrynkybe4ntcqok5sjfib67vga54ze6srhgyqvis2mjfm42q",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnclpvdbh672"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiajyzwqwbn4foqydui5u77akb4dela5sn3sxa5dclo6habrdal4uy"
    },
    "mimeType": "image/jpeg",
    "size": 516555
  },
  "path": "/news/2026-06-glp-linked-breast-cancer-incidence.html",
  "publishedAt": "2026-06-02T08:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, Ph.D., a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penn's Abramson Cancer Center.",
  "title": "GLP-1 use linked to lower breast cancer incidence in large cohort study"
}